SI-BONE, INC. Debt Securities, Available-for-sale, Current
SI-BONE, INC. (SIBN) had Debt Securities, Available-for-sale, Current of $76.57 million as of 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2023-03-02
- 2022-12-31: Debt Securities, Available-for-sale, Current $76.57M.
- 2021-12-31: Debt Securities, Available-for-sale, Current $83.56M.
- 2021-09-30: Debt Securities, Available-for-sale, Current $100.99M.
- 2021-06-30: Debt Securities, Available-for-sale, Current $128.51M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2022-12-31 | $76.57M 10-K · filed 2023-03-02 |
| 2021-12-31 | $83.56M 10-K · filed 2023-03-02 |
| 2021-09-30 | $100.99M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $128.51M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $147.69M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $142.85M 10-K · filed 2022-03-01 |
| 2020-09-30 | $76.02M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $71.50M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $77.37M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $81.34M 10-K · filed 2021-03-10 |
| 2019-09-30 | $83.61M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $91.78M 10-Q · filed 2019-08-07 |
| 2018-12-31 | $97.10M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |